DNTH
Price
$78.75
Change
+$4.21 (+5.65%)
Updated
Oct 20 closing price
Capitalization
4.4B
16 days until earnings call
Intraday BUY SELL Signals
TECX
Price
$21.82
Change
+$0.68 (+3.22%)
Updated
Oct 20 closing price
Capitalization
426.66M
16 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DNTH vs TECX

DNTH vs TECX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
DNTH vs. TECX commentary
Oct 21, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNTH is a Hold and TECX is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for DNTH with price predictions
Oct 19, 2026

Momentum Indicator for DNTH turns negative, indicating new downward trend

DNTH saw its Momentum Indicator move below the 0 level on September 15, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 94 similar instances where the indicator turned negative. In 85 of the 94 cases, the stock moved further down in the following days. The odds of a decline are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

DNTH moved below its 50-day moving average on September 15, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for DNTH crossed bearishly below the 50-day moving average on September 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 76%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DNTH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.

The Aroon Indicator for DNTH entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 18 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1.33% 3-day Advance, the price is estimated to grow further. Considering data from situations where DNTH advanced for three days, in 240 of 294 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

DNTH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 18 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 30 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. DNTH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 77 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.758) is normal, around the industry mean (2.978). P/E Ratio (-18.573) is within average values for comparable stocks, (-0.692). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (134.267) among similar stocks. DNTH's P/S Ratio (2500.000) is slightly higher than the industry average of (438.009).

The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
a Summary for TECX with price predictions
Oct 19, 2026

TECX's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for TECX turned positive on October 08, 2026. Looking at past instances where TECX's MACD turned positive, the stock continued to rise in 44 of 47 cases over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where TECX's RSI Oscillator exited the oversold zone, 29 of 33 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 88%.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +2.73% 3-day Advance, the price is estimated to grow further. Considering data from situations where TECX advanced for three days, in 215 of 248 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.

TECX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TECX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.

The Aroon Indicator for TECX entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 25 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.906) is normal, around the industry mean (2.978). P/E Ratio (-4.776) is within average values for comparable stocks, (-0.692). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (134.267) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).

The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. TECX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 99 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TECX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
DNTH vs TECX: Fundamental Ratings
DNTH
TECX
OUTLOOK RATING
1..100
5155
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
25
Undervalued
PROFIT vs RISK RATING
1..100
30100
SMR RATING
1..100
9697
PRICE GROWTH RATING
1..100
5050
P/E GROWTH RATING
1..100
1899
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECX's Valuation (25) in the null industry is somewhat better than the same rating for DNTH (77). This means that TECX’s stock grew somewhat faster than DNTH’s over the last 12 months.

DNTH's Profit vs Risk Rating (30) in the null industry is significantly better than the same rating for TECX (100). This means that DNTH’s stock grew significantly faster than TECX’s over the last 12 months.

DNTH's SMR Rating (96) in the null industry is in the same range as TECX (97). This means that DNTH’s stock grew similarly to TECX’s over the last 12 months.

DNTH's Price Growth Rating (50) in the null industry is in the same range as TECX (50). This means that DNTH’s stock grew similarly to TECX’s over the last 12 months.

DNTH's P/E Growth Rating (18) in the null industry is significantly better than the same rating for TECX (99). This means that DNTH’s stock grew significantly faster than TECX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DNTHTECX
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 6 days ago
90%
N/A
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 20 days ago
82%
Bullish Trend 12 days ago
87%
Declines
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 7 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
COMPARISON
Comparison
Oct 21, 2026
Stock price -- (DNTH: $78.75 vs. TECX: $21.83)
Brand notoriety: DNTH and TECX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNTH: 201% vs. TECX: 74%
Market capitalization -- DNTH: $4.4B vs. TECX: $426.66M
DNTH [@Biotechnology] is valued at $4.4B. TECX’s [@Biotechnology] market capitalization is $426.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.44B. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNTH’s FA Score shows that 2 FA rating(s) are green while TECX’s FA Score has 1 green FA rating(s).

  • DNTH’s FA Score: 2 green, 3 red.
  • TECX’s FA Score: 1 green, 4 red.
According to our system of comparison, DNTH is a better buy in the long-term than TECX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNTH’s TA Score shows that 4 TA indicator(s) are bullish while TECX’s TA Score has 5 bullish TA indicator(s).

  • DNTH’s TA Score: 4 bullish, 5 bearish.
  • TECX’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, TECX is a better buy in the short-term than DNTH.

Price Growth

DNTH (@Biotechnology) experienced а +1.51% price change this week, while TECX (@Biotechnology) price change was +2.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.45%. For the same industry, the average monthly price growth was -16.03%, and the average quarterly price growth was -14.84%.

Reported Earning Dates

DNTH is expected to report earnings on Nov 05, 2026.

TECX is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Biotechnology (-0.45% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
DNTH
Daily Signal:
Gain/Loss:
TECX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
YBTC18.760.15
+0.81%
Roundhill Bitcoin Covered Call Strategy ETF (YBTC)
PXF76.420.53
+0.70%
Invesco RAFI Developed Markets ex-U.S. ETF (PXF)
NCIQ15.90N/A
N/A
Hashdex Nasdaq CME Crypto Index ETF
WEPN38.51-0.17
-0.45%
Nicholas Defense And Rare Earth Income ETF
MARS22.08-0.23
-1.03%
Roundhill Space & Technology ETF (MARS)

DNTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNTH has been loosely correlated with EDIT. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if DNTH jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNTH
1D Price
Change %
DNTH100%
+5.65%
EDIT - DNTH
48%
Loosely correlated
+6.61%
PTGX - DNTH
46%
Loosely correlated
+2.64%
IMTX - DNTH
45%
Loosely correlated
+6.52%
XENE - DNTH
45%
Loosely correlated
+3.39%
XNCR - DNTH
45%
Loosely correlated
+7.55%
More

TECX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TECX has been loosely correlated with ENVB. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if TECX jumps, then ENVB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TECX
1D Price
Change %
TECX100%
+3.19%
ENVB - TECX
61%
Loosely correlated
+3.60%
IGC - TECX
49%
Loosely correlated
+1.24%
DNTH - TECX
40%
Loosely correlated
+5.65%
KURA - TECX
40%
Loosely correlated
+6.62%
SLDB - TECX
39%
Loosely correlated
+8.11%
More